We are live on
!
Find out more
BioMarin Pharmaceuticals
BMRN
BMRN
538 hedge funds and large institutions have $11.2B invested in BioMarin Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 169 increasing their positions, 210 reducing their positions, and 127 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% more call options, than puts
Call options by funds: $120M | Put options by funds: $70.8M
15% more capital invested
Capital invested by funds: $9.72B → $11.2B (+$1.46B)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
4.48% more ownership
Funds ownership: 93.49% → 97.97% (+4.5%)
7% less funds holding
Funds holding: 576 → 538 (-38)
20% less repeat investments, than reductions
Existing positions increased: 169 | Existing positions reduced: 210
20% less first-time investments, than exits
New positions opened: 101 | Existing positions closed: 127
Holders
538
Holders Change
-38
Holders Change %
-6.6%
% of All Funds
6.55%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.1%
New
101
Increased
169
Reduced
210
Closed
127
Calls
$120M
Puts
$70.8M
Net Calls
+$48.9M
Net Calls Change
+$17.3M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$158M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$124M |
| 3 |
Goldman Sachs
New York
|
-$100M |
| 4 |
State Street
Boston,
Massachusetts
|
-$67.6M |
| 5 |
Man Group
London,
United Kingdom
|
-$61.6M |
